Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

QIAGEN N.V. (QGEN)

39.54   -0.32 (-0.8%) 07-19 16:03
Open: 39.77 Pre. Close: 39.86
High: 39.8 Low: 39.54
Volume: 840,772 Market Cap: 8974M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 39.847 - 40.056 40.056 - 40.235
Low: 39.034 - 39.276 39.276 - 39.482
Close: 39.146 - 39.553 39.553 - 39.9

Technical analysis

as of: 2019-07-22 1:40:58 AM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 47.40     One year: 48.38
Support: Support1: 39.22    Support2: 32.63
Resistance: Resistance1: 40.58    Resistance2: 41.42
Pivot: 40.05
Moving Average: MA(5): 39.71     MA(20): 40.13
MA(100): 39.32     MA(250): 37.60
MACD: MACD(12,26): 0.05     Signal(9): 0.19
Stochastic oscillator: %K(14,3): 25.73     %D(3): 25.30
RSI: RSI(14): 46.60
52-week: High: 41.55  Low: 32.33  Change(%): 7.1
Average Vol(K): 3-Month: 105627  10-Days: 51954

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
QGEN has closed above bottom band by 20.4%. Bollinger Bands are 35.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 16 Jul 2019 14:07:54 Z
QGEN Crosses Above Average Analyst Target

Fri, 12 Jul 2019 21:08:36 Z
Here's Why NeoGenomics Stock Rose 74% in the First Half of the Year

Tue, 09 Jul 2019 16:13:48 Z
Inovio Ends Enrollment in Vulvar Dysplasia Study on VGX-3100

Thu, 27 Jun 2019 16:16:41 Z
Inovio Up on Enrollment Closure in Cervical Dysplasia Study

Thu, 20 Jun 2019 14:42:46 Z
QIAGEN Inks Distribution Deal With Mckesson Medical-Surgical

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 226.97
Shares Float (M) 218.49
% Held by Insiders 2.76
% Held by Institutions 72.73
Shares Short (K) 3840
Shares Short P. Month (K)

Stock Financials

EPS 0.810
EPS Est. Current Year 1.180
EPS Est. Next Year 1.320
EPS Est. Next Quarter 0.420
Forward EPS 1.500
Book Value (p.s.) 11.480
PEG Ratio 2.53
Profit Margin 12.45
Operating Margin 18.84
Return on Assets (ttm) 3.4
Return on Equity (ttm) 7.2
Qtrly Rev. Growth 1.5
Gross Profit (p.s.) 4.406
Sales Per Share
EBITDA (p.s.) 2.112
Qtrly Earnings Growth -8.60
Operating Cash Flow (M) 356.02
Levered Free Cash Flow (M) 244.09

Stock Valuations

P/E 48.81
P/E Growth Ratio -0.01
P/BV 3.44
P/S 1347506688.00
P/CF 25.21

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-01-25
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.